Liberty Mutual Group Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,795	Closed	-$2.91M	–	134
2022 Q1	$2.91M	Buy	+24,795	New	+$2.87M	0.1%	70
2021 Q2	–	Sell	-30,281	Closed	-$3.9M	–	22
2021 Q1	$3.9M	Buy	+30,281	New	+$4.6M	0.24%	12

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Liberty Mutual Group Asset Management's ASND Position: Q2 2022 in Review

Liberty Mutual Group Asset Management sold out of Ascendis Pharma A/S (ASND) in Q2 2022, closing a stake of 24,795 shares — an estimated $2.91M sold.

Liberty Mutual Group Asset Management first reported a position in ASND in Q1 2021 and held it in 2 quarters. The position peaked at $3.9M in Q1 2021. 167 funds tracked by Wall St. Rank hold ASND as of Q2 2022.

Liberty Mutual Group Asset Management reported no remaining Ascendis Pharma A/S position as of Q2 2022 after selling out during the quarter.
Liberty Mutual Group Asset Management sold 24,795 Ascendis Pharma A/S shares in Q2 2022, an estimated $2.91M.
Liberty Mutual Group Asset Management first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 2 quarters.
Liberty Mutual Group Asset Management's Ascendis Pharma A/S position peaked at $3.9M in Q1 2021.
167 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2022.

Based on Liberty Mutual Group Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.